A--Contract Research Organization for the National In

Questions & Answers / Clarifications

This document provides answers to vendor questions regarding Solicitation RFP 75N94025R00008 for Clinical Research Organization services for the National Institute on Alcoholism and Alcohol Abuse Medications Development Clinical Trials Network.

• Incumbent Contractor: Fast-Track Drugs & Biologics, LLC.
• Definition of "Days": Unless otherwise specified, "days" refers to calendar days. Deliverables due on weekends or holidays are due the following business day.
• Key Personnel: Anticipated Key Personnel for the awarded contract include Project Director, Senior Clinical Manager (Monitor), and Director of Biostatistics.
• Cloud Services/FedRAMP: A commercial off-the-shelf (COTS) system with an active FISMA Moderate Authorization to Operate (ATO) will be considered if it resides on a FedRAMP certified cloud infrastructure or platform, subject to NIH review.
• Budget Template: Offerors MUST use the NIH excel budget template (Attachment 10); personal cost sheets are not permitted.
• Reproducibility Policy: Offerors must describe their systematic approach to evaluating and communicating prior research strengths and limitations in their technical proposal.
• Page Limits: There are no page limits for the Technical Proposal, Business Proposal, or attachments.
• Data Management and Sharing Plan: This plan must be submitted as part of the Technical Proposal.
• Technical Proposal Submission: The Technical Proposal must be a single document addressing the base IDIQ and including separate sections for the two task orders.
• Monitoring Visits: 20 monitoring visits are expected per site, and visits are generally on-site (Initiation: 2 days; Interim: 1 day; Close-out: 1 day).
• DSMB Teleconferences: Assume 1 teleconference every 6 months with 3 members, conducted remotely.
• eTMF: An electronic Trial Master File (eTMF) is expected for the management of essential records.

This amendment clarifies several aspects of the solicitation, including personnel requirements, submission formats, and technical expectations. It also adds specific content to the Technical Proposal instructions regarding reproducibility. Offerors should review these clarifications carefully to ensure their proposals meet all requirements.

Amendment / Modification

This amendment (0001) to solicitation 75N94025R00008 serves two primary purposes:

1. Answers to Vendor Questions: It provides responses to questions received from potential offerors. These Q&As are detailed in an attached 6-page document titled "Amendment 0001 Questions and Answers RFP 75N94025R00008".
2. Technical Proposal Instructions Update: Section L, "Technical Proposal Instructions," specifically item d, "Enhancing Reproducibility through Rigor and Transparency" (on page 108 of the original RFP), has been amended. Previously missing specification language has been added to provide clearer guidance to offerors on how to address this item within their Technical Proposals. Further details regarding this update can be found in Question number 6 of the attached "Amendment 0001 Questions and Answers RFP 75N94025R00008".

• Section L, "Technical Proposal Instructions," item d.

• An attached document containing Questions and Answers.

• The amendment provides clarifications and updated instructions for technical proposals. Offerors should review the attached Q&A document and the revised Section L instructions carefully to ensure their proposals are compliant. The effective date of this amendment is April 23, 2026.

Form / Attachment / Pricing Sheet

This document provides "Additional Proposal Information and Instructions" to assist offerors in preparing their proposals for RFP 75N94025R00008, "Contract Research Organization for the NIAAA Medications Development Clinical Trials Network". It offers guidance, uniform cost assumptions, and clarifications beyond the main solicitation documents.

• Task Order Preparation: Offerors must prepare separate Excel budget proposals for two task order requirements:
  • Base IDIQ contract task order (Core and Study Development Support).
  • A "sample" task order for technical and overall proposal evaluation (Phase 2 Proof of Concept Medication Clinical Trial).
• Cost/Effort Assumptions: Provides detailed assumptions for both task orders, including:
  • Core Task Order: Cost plus fixed fee, 12-month base period with six 12-month options (7-year total potential performance). Estimated annual effort for Project Director, Medical Writer, and Biostatistician. Assumes no travel costs but includes teleconferencing and FDA submission costs. Includes a 2.4% annual inflation rate.
  • Sample Task Order: Cost plus fixed fee, completion type. Details include 5 clinical sites, 200 participants, double-blind/placebo-controlled study, 14-week treatment period, and specific monitoring visits. Period of performance is 2 years and 2 months with a 2.6% annual inflation rate.
• Section 508 Accessibility: Guidance on completing VPAT (Voluntary Product Accessibility Template) for Section 508 accessibility, specifying applicable standards (Functional Performance, Hardware, Software, Support Services, WCAG Level A/AA) and the forms to use (VPAT 2.5Rev508 and VPAT 2.5Rev WCAG).
• Limitations on Subcontracting: A reminder for 100% Small Business Set-Asides, emphasizing that the prime contractor cannot pay more than 50% of the contract performance to subcontractors that are not similarly situated.
• Prime Contractor Expertise: Requirement for the prime contractor to have expertise in managing subcontractors.
• Referencing Other Sections: Directs offerors to also reference RFP Section J (List of Attachments) and Section L (Proposal Instructions).

This document is critical for bidders to understand the specific cost assumptions, period of performance, and evaluation requirements for the task orders. It also outlines important compliance requirements related to Section 508 accessibility and subcontracting limitations, which directly impact proposal preparation and business strategy.

Solicitation / RFP / RFQ

This solicitation is for Contract Research Organization (CRO) support services to assist the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in study development and data management for multiple, multi-center, pharmacotherapy clinical trials for the treatment of Alcohol Use Disorder. Services include study development support, regulatory affairs preparation, Good Clinical Practice (GCP) monitoring, study document preparation, electronic clinical data capture and monitoring, acquisition and facilitation of study medication, regulatory support, statistical and data analysis, and final clinical study report formatting and preparation.

• Statement of Work (SOW): The contractor shall provide all necessary services, personnel, material, equipment, and facilities not otherwise provided by the Government, as needed to perform the requirements in the Base IDIQ Contract Statement of Work (dated 01/16/2026).

• Task Orders: Work will be performed only as directed by Task Orders issued by the Contracting Officer.

• Reporting: Task Order Technical Progress Reports, Summary of Salient Results (max 200 words), and other deliverables as specified in "List of Possible Deliverables for Task Orders Issued Under the Base IDIQ Contract". Reports must comply with Section 508 of the Rehabilitation Act.

• Invention Reporting: Required for patent rights and government support certification.

• Data Management and Sharing: Offerors must submit a plan for data management and sharing or explain why it's not possible.

• Contract Type: Single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract.

• Period of Performance: Seven-year ordering period (anticipated 11/15/2026 - 11/14/2033), with an option to extend by six months.

• Estimated Value: Guaranteed minimum of $5,000; maximum ceiling of $18,000,000.

• Task Orders: Cost-plus-fixed-fee type task orders will be issued.

• Proposal Submission: Electronically via the NIH electronic Contract Proposal Submission (eCPS) website.

• Proposal Due Date: June 10, 2026, by 4:30 PM Eastern Daylight Time.

• Offer Validity: 180 days.

• Questions Deadline: May 13, 2026, submitted via email.

• Evaluation Factors: Technical, Cost/Price, and Past Performance (in order of importance).

• 100% Small Business Set-Aside.

• Offerors must be registered in the System for Award Management (SAM).

• Specific security, privacy, and IT requirements are detailed throughout the document, including FIPS 140 validation, encryption, and incident response protocols.

Statement of Work (SOW) / Performance Work Statement (PWS)

This Statement of Work (SOW) outlines the requirements for a Contract Research Organization (CRO) to conduct Phase II, Proof of Concept clinical trials for the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Medications Development Branch Extramural Clinical Program. The goal is to test promising compounds for the treatment of Alcohol Use Disorder (AUD).

• The Contractor shall serve as the CRO, managing and overseeing all aspects of multiple, multi-center, pharmacotherapy clinical trials.

• This includes clinical trial coordination, site oversight, study document preparation, electronic data capture, GCP monitoring, packaging, shipping, and data management.

• Specifically, this SOW covers a Phase II, Proof of Concept Clinical Trial at 5 NIAAA contract clinical sites (3 East Coast, 1 West Coast, 1 Colorado).

• The trial will be double-blind, placebo-controlled.

• Participants: 200 (100 per arm), 40 per clinical site.

• Study duration: 14 weeks (12 weeks treatment, 2 weeks follow-up).

• Monitoring visits: 20 total (18 during study, 1 initiation, 1 close-out).

• Recruitment rate: 3 participants randomized per month per site.

• Period of performance: Approximately 2 years and 2 months (6 months start-up, 15 months recruitment, 3 months data lock, 2 months analysis/close-out).

• The period of performance is approximately 2 years and 2 months.

• The trial will be conducted at 5 clinical sites across the US.

• Contractor must provide all necessary services, qualified personnel, material, equipment, and facilities.

• Contractor is responsible for blister packaging, kitting, randomization, and site distribution/tracking of investigational products.

• An independent Data and Safety Monitoring Board (DSMB) will monitor the trials.

• The Contractor must establish and oversee the DSMB.

• The Contractor must work with clinical sites to obtain and maintain IRB approval.

• Research involving human subjects is not to be conducted under this contract until specific certifications and approvals are provided.

Form / Attachment / Pricing Sheet

This document is a "Proposal Intent Response Form" for RFP No: 75N94025R00008, titled "Clinical Research Organization for the NIAAA Medications Development Clinical Trials Network." It is used by potential bidders to indicate whether they intend to submit a proposal.

• Bidders must choose one of two options: "Do intend to submit a proposal" or "Do Not intend to submit a proposal."
• If not responding, bidders are asked to provide their reason(s).
• Bidders are required to provide contact information, including Name, Title, Organization, and E-mail.

This form is crucial for bidders to communicate their intent to the government. Returning this form helps the government in planning for proposal evaluation. The information provided is not binding but is requested by the "earliest practical date" and should be returned to the Contracting Officer/Contract Specialist identified in Section A-Solicitation/Contract Form.

Form / Attachment / Pricing Sheet

This document provides detailed instructions and requirements for submitting invoices and receiving payments for contractors working with NIH. It outlines the "Prompt Payment" clause and specific NIH implementation requirements, as well as electronic submission procedures.

• Invoice Requirements: Specifies 12 mandatory items for a proper invoice, including vendor/contractor details, remit-to address, invoice number, NBS document numbers, Unique Entity Identifier (UEI), Federal Taxpayer Identification Number (TIN) or Vendor Identification Number (VIN), three-way match identification, description of supplies/services, freight charges, and quantity/unit/price details.
• Invoice Submission: Invoices must be submitted electronically to the Department of Treasury's Invoice Processing Platform (IPP) at https://www.ipp.gov, with a copy to the Approving Official (Contracting Officer) and Contracting Officer Representative.
• Payment Terms: Payment is generally due 30 days after receipt of a proper invoice or 30 days after Government acceptance of supplies/services, whichever is later. Specific terms apply to perishable goods.
• Interest Penalties: Details conditions under which interest penalties may be paid for late payments.
• Accelerated Payments to Small Business Subcontractors: Outlines requirements for contractors to make accelerated payments to their small business subcontractors within 15 days of receiving accelerated payments from the Government.
• Electronic Submission: Reinforces the requirement for electronic submission of payment requests via IPP, with provisions for alternate procedures authorized in writing by the Contracting Officer.

This document is critical for any bidder seeking to understand the financial and administrative processes related to contract payments. It details the exact format and information required for invoices, the payment timeline, and the mandatory electronic submission process. Failure to comply with these requirements could lead to payment delays or rejections. It also highlights requirements for passing accelerated payments to small business subcontractors.

Statement of Work (SOW) / Performance Work Statement (PWS)

To support the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Medications Development Clinical Trials Network by providing core and study development support services for potential new studies.

• Conduct literature reviews on investigational products for alcohol use disorder.

• Assist in the development of new clinical protocols in accordance with FDA and ICH guidelines.

• Prepare and submit regulatory affairs materials, including pre-IND meeting packages and FDA submissions.

• Respond to inquiries and coordinate logistics for virtual meetings related to potential new studies and investigational products.

• Deliverables include Literature Review/Findings, FDA Pre-IND Meeting Package, Draft Protocol, Meeting/Teleconference Minutes, and Annual Report of Task Order Activities.

• Specific due dates are provided for each deliverable.

• All electronic reports and deliverables must comply with Revised Section 508 Standards.

• Base performance period of 12 months with six successive 12-month option periods, for a total potential performance period of 7 years.

• The contractor shall provide all necessary labor, materials, supplies, equipment, facilities, and services.

• A Service Contract Annual Report is required if the total task order value is above SAT $350K.

• Compliance with Section 508 Standards is mandatory for all electronic reports and deliverables.

Form / Attachment / Pricing Sheet

This document provides instructions and requirements for offerors to submit a Supply Chain Risk Assessment Certification as part of their proposal. It outlines the definitions related to supply chain risk and specifies the information and representations required from the offeror.

• Definitions: Clarifies terms such as "Mission-critical acquisition," "State-owned enterprise," and "Supply chain risk."
• Required Information Submittal (Paragraph c): Offerors must provide:
  • Description of products, materials, information, or services.
  • Vendor and manufacturer's company name and address.
  • Vendor and manufacturer's website, CAGE code, and UEI (if known).
• Representations (Paragraph d): Offerors must represent whether they have:
  • Foreign ownership exceeding 10% of total shares.
  • Specific business affiliations with foreign entities (e.g., technology partnerships, joint ventures).
  • Investments or ownership interest from foreign governments or state-owned enterprises.
  • Substantial ties of company leadership to foreign countries.
  • Violated export controls or the Foreign Corrupt Practices Act.
  • Been prohibited from doing business with U.S. or foreign governments.
  • Affiliations with prohibited entities.
  • Been suspended or debarred.
  • Filed for or is currently in bankruptcy or litigation.
• Subcontracts (Paragraph g): Offerors must include these requirements in subcontracts for mission-critical products, materials, information, or services and submit subcontractor information with their proposal.

This attachment is critical for bidders to understand the specific requirements for assessing and certifying their supply chain risk. Failure to provide the required information or additional information requested by the Contracting Officer may result in the offeror being deemed non-responsible and ineligible for award. Bidders must carefully review and complete all sections of this certification and ensure compliance with the outlined representations and subcontracting requirements.

Statement of Work (SOW) / Performance Work Statement (PWS)

This Statement of Work (SOW) outlines the requirements for a Contract Research Organization (CRO) to conduct pharmacotherapy clinical trials for the treatment of Alcohol Use Disorder (AUD) under the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Medications Development Branch (MDB) Extramural Clinical Program. The goal is to accelerate the search for new and more effective medications for AUD.

The Contractor will be responsible for all aspects of multiple, multi-center clinical trials, including:

• Clinical trial coordination and site oversight

• Study document preparation and management

• Electronic data capture and management

• Good Clinical Practice (GCP) monitoring

• Acquisition and coordination of study medication

• Logistical and meeting services

• Regulatory support

• Statistical and data analysis

• Final clinical study report preparation It is anticipated that 4-6 trials will be completed during the life of the Indefinite Delivery, Indefinite Quantity (IDIQ) contract.

• Trials will be monitored by an independent Data and Safety Monitoring Board (DSMB).

• The CRO will consult regularly with NIAAA staff to establish research priorities and provide status updates.

• The CRO must adhere to FDA and International Conference on Harmonization (ICH) guidelines.

• Specific deliverables include Regulatory Plans, Medication Plans, Protocols, Manuals of Operations, Standard Operating Procedures, and Monitoring Plans, with defined submission timelines.

Not explicitly defined in this SOW, but it pertains to clinical trials conducted at NIAAA contract clinical sites.

• The CRO must have a Principal Investigator with an advanced academic degree (Ph.D. or M.D.).
• The CRO is responsible for managing regulatory affairs, including IND preparation and FDA submissions.
• The CRO must establish and oversee a Data and Safety Monitoring Board (DSMB).
• The CRO must work with clinical sites to obtain and maintain single IRB approval.
• Research involving human subjects requires specific certifications and approvals.
• The CRO must implement secure data management systems (CDMS, EDC, ECM) and ensure data integrity and confidentiality.
• The CRO is responsible for subject recruitment, data collection and storage, monitoring, quality control, and reporting.
• A transition plan is required prior to task order expiration.

Form / Attachment / Pricing Sheet

This document provides instructions for packaging and delivering proposals for RFP 75N94025R00008 to the NIH electronic Contract Proposal Submission (eCPS) website. It details the required file formats, naming conventions, and general formatting guidelines for proposals.

• Proposal Submission: Must be submitted via the eCPS website (https://ecps.nih.gov). Facsimile or email submissions are not accepted. Allow up to three business days for account creation.
• File Creation:
  • One PDF file for the Technical Proposal (searchable).
  • One PDF file for the Business Proposal (searchable).
  • Separate Excel files for the "Breakdown of Proposed Estimated Costs (plus Fee)" for each task order requirement (must be in original Excel format, not PDF).
• File Naming Convention: Offeror Name_Solicitation Number_Proposal Type (e.g., XYZ Company_NIHAI2012001_Technical.pdf).
• Formatting:
  • Letter size (8.5" x 11").
  • No internet links or alternate sources.
  • No audio or video files.
  • Font size: 10-12 points.
  • Spacing: Max 15 characters per inch, max 6 lines per vertical inch.
  • Margins: At least one inch on all sides.

Adherence to these instructions is critical for proposal submission. Failure to follow formatting requirements may impact the review of the proposal. Bidders must ensure their proposals are submitted correctly and on time via the eCPS website, with all required files in the specified formats and naming conventions.

Form / Attachment / Pricing Sheet

This document, "List of Possible Deliverables for Task Orders Issued Under the Base IDIQ Contract," details the reporting requirements and deliverables expected for task orders under an existing Indefinite Delivery, Indefinite Quantity (IDIQ) contract. It serves as a guide for potential bidders on the types of outputs and their associated timelines.

• Technical Reports Delivery and Distribution Schedule: Outlines various reports such as Literature Review/Findings, FDA Pre-IND Meeting Packages, Protocols, Regulatory Plans, Medication Plans, Manuals of Operations, Standard Operating Procedures, Monitoring Plans, Analytical Plans, and Data Management Plans. Specific due dates are generally "To be specified in Task Order," with typical timeframes provided (e.g., "2 weeks from date of COR request").
• Reoccurring Deliverables: Includes items like Monitoring Reports, Updates to protocols/CRFs/MOP, FDA IND reports, Quarterly Study Progress Reports, Quarterly Financial Reports, Annual Progress and Financial Reports, and Meeting/Teleconference Minutes.
• Final Reports: Specifies deliverables such as the Final Clinical Study Report, Complete Data Set, Statistical Code and Algorithms, and final versions of various plans and reports.
• IT and Administrative Reports: Lists requirements for Roster of Employees, NIH IT Security Awareness Training, Information Technology System Security Plans, IT Security Authorization documentation, and reporting of new/departed employees, vulnerability scanning, Section 508 Annual Reports, and Financial Conflict of Interest.
• Submission Information: Specifies that electronic reports must comply with Revised Section 508 Standards. It also provides contact information for the Contracting Officer's Representative (COR), Contracting Officer (CO), and Information Systems Security Officer (ISSO), whose emails will be provided after award.

This attachment is crucial for bidders to understand the scope and nature of deliverables expected under potential task orders. It highlights the types of reports, data, and administrative documentation that will be required, along with general timelines. This information is essential for developing accurate proposals, resource planning, and understanding the ongoing reporting obligations throughout the life of any awarded task order.

Form / Attachment / Pricing Sheet

This document, "Section K - Representations, Certifications, and Other Statements of Offerors," is a mandatory part of the offeror's business proposal. It requires the offeror to provide specific representations and certifications to the government.

This section is comprised of eight parts, including:

• Annual Representations and Certifications (FAR 52.204-8), which requires the offeror to identify the NAICS code and small business size standard for the acquisition, and to confirm their SAM registration status.
• Commercial and Government Entity Code Reporting (FAR 52.204-16).
• Information Regarding Responsibility Matters (FAR 52.209-7), which requires disclosure of past proceedings and potential liabilities.
• Cost Accounting Standards Notices and Certification (FAR 52.230-1), which applies to offerors not classified as small businesses or foreign governments.
• Certification Regarding Environmental Tobacco Smoke (Pro-Children Act of 1994).
• Certification of Institutional Policy on Financial Conflicts of Interest (applicable to R&D contracts).
• Disaster or Emergency Area Representation (FAR 52.226-3), if applicable to the acquisition.
• Alternate Representation by Corporations Regarding an Unpaid Delinquent Tax Liability or a Felony Conviction.

Offerors must complete and submit this document as part of their proposal. Failure to provide accurate and complete representations and certifications may impact their eligibility or the evaluation of their offer. The document outlines various compliance requirements and self-certifications necessary for participating in the acquisition.